These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 20857187)

  • 41. Neurocognitive symptoms and impairment in an HIV community clinic.
    Kim DH; Jewison DL; Milner GR; Rourke SB; Gill MJ; Power C
    Can J Neurol Sci; 2001 Aug; 28(3):228-31. PubMed ID: 11513341
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neurocognitive functioning in MDR-TB patients with and without HIV in KwaZulu-Natal, South Africa.
    Ramlall S; Lessells RJ; Naidu T; Sandra Mthembu S; Padayatchi N; Burns JK; Tomita A
    Trop Med Int Health; 2020 Aug; 25(8):919-927. PubMed ID: 32428324
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Which Patient Characteristics Among Cocaine Users with HIV Relate to Drug Use and Adherence Outcomes Following a Dual-Focused Intervention?
    Read G; Ingersoll KS
    AIDS Behav; 2016 Mar; 20(3):633-45. PubMed ID: 26142103
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The relationship between premorbid IQ and neurocognitive functioning in individuals with cocaine use disorders.
    Mahoney JJ; Kalechstein AD; De Marco AP; Newton TF; De La Garza R
    Neuropsychology; 2017 Mar; 31(3):311-318. PubMed ID: 28054825
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association Between Cognitive Tests and Antiretroviral Medication Adherence in Older Adults With HIV.
    Caballero J; Ownby RL; Jacobs RJ; Thomas JE; Schweizer MS
    Ann Pharmacother; 2019 Feb; 53(2):151-158. PubMed ID: 30175588
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS.
    Ettenhofer ML; Foley J; Castellon SA; Hinkin CH
    Neurology; 2010 Apr; 74(15):1217-22. PubMed ID: 20220123
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of substance use and cognitive impairment on adherence to antiretroviral therapy in HIV+ patients.
    Sánchez-Rivero I; Madoz-Gúrpide A; Parro-Torres C; Hernández-Huerta D; Ochoa Mangado E
    Adicciones; 2020 Jan; 32(1):7-18. PubMed ID: 30627722
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of neuropsychological performance on everyday functioning between older and younger adults with and without HIV.
    Vance DE; Fazeli PL; Gakumo CA
    J Assoc Nurses AIDS Care; 2013; 24(2):112-25. PubMed ID: 22943982
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women.
    Cohen RA; Boland R; Paul R; Tashima KT; Schoenbaum EE; Celentano DD; Schuman P; Smith DK; Carpenter CC
    AIDS; 2001 Feb; 15(3):341-5. PubMed ID: 11273214
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Directly observed antiretroviral therapy eliminates adverse effects of active drug use on adherence.
    Nahvi S; Litwin AH; Heo M; Berg KM; Li X; Arnsten JH
    Drug Alcohol Depend; 2012 Jan; 120(1-3):174-80. PubMed ID: 21885212
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gender and other psychosocial factors as predictors of adherence to highly active antiretroviral therapy (HAART) in adults with comorbid HIV/AIDS, psychiatric and substance-related disorder.
    Applebaum AJ; Richardson MA; Brady SM; Brief DJ; Keane TM
    AIDS Behav; 2009 Feb; 13(1):60-5. PubMed ID: 18690532
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Associations between use of crack cocaine and HIV-1 disease progression: research findings and implications for mother-to-infant transmission.
    Cook JA
    Life Sci; 2011 May; 88(21-22):931-9. PubMed ID: 21219914
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of cocaine and HIV on decision-making abilities.
    Nigro SE; Wu M; C Juliano A; Flynn B; Lu LH; Landay AL; French AL; Yang S
    J Neurovirol; 2021 Jun; 27(3):422-433. PubMed ID: 33978905
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Motor function and human immunodeficiency virus-associated cognitive impairment in a highly active antiretroviral therapy-era cohort.
    Robinson-Papp J; Byrd D; Mindt MR; Oden NL; Simpson DM; Morgello S;
    Arch Neurol; 2008 Aug; 65(8):1096-101. PubMed ID: 18695060
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cocaine dependence does not contribute substantially to white matter abnormalities in HIV infection.
    Cordero DM; Towe SL; Chen NK; Robertson KR; Madden DJ; Huettel SA; Meade CS
    J Neurovirol; 2017 Jun; 23(3):441-450. PubMed ID: 28251596
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictors and Evolution of Antiretroviral Therapy Adherence Among Perinatally HIV-Infected Adolescents in Brazil.
    Côté J; Delmas P; de Menezes Succi RC; Galano E; Auger P; Sylvain H; Colson S; Machado DM
    J Adolesc Health; 2016 Sep; 59(3):305-310. PubMed ID: 27320032
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment.
    Tozzi V; Balestra P; Galgani S; Narciso P; Ferri F; Sebastiani G; D'Amato C; Affricano C; Pigorini F; Pau FM; De Felici A; Benedetto A
    AIDS; 1999 Oct; 13(14):1889-97. PubMed ID: 10513647
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HIV viremia contributes to neurocognitive impairments in persons who use cocaine.
    Al-Khalil K; Towe SL; Ikner TP; Meade CS
    J Neurovirol; 2023 Jun; 29(3):331-336. PubMed ID: 36857016
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between smoking, crack cocaine abuse and the discontinuation of combination antiretroviral therapy in Recife, Pernambuco, Brazil.
    Batista Jd; Albuquerque Mde F; Santos ML; Miranda-Filho Dde B; Lacerda HR; Maruza M; Moura LV; Coimbra I; Ximenes RA
    Rev Inst Med Trop Sao Paulo; 2014; 56(2):127-32. PubMed ID: 24626414
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users.
    Arnsten JH; Demas PA; Grant RW; Gourevitch MN; Farzadegan H; Howard AA; Schoenbaum EE
    J Gen Intern Med; 2002 May; 17(5):377-81. PubMed ID: 12047736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.